ESR2 and cardiac hypertrophy: In relation to the heart muscle, estrogens via receptors ERα, ERβ and GPER have an inhibitory effect on cardiac hypertrophy, inflammation, fibrosis, and oxidative stress, which has been confirmed in animal and humans models (32–35).